|Treatment of acute hepatitis C with interferon alfa-2b|
E Jaeckel, M Cornberg, H Wedemeyer, T Santantonio, J Mayer, M Zankel, ...
New England Journal of Medicine 345 (20), 1452-1457, 2001
|Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors|
V Tozzi, P Balestra, R Bellagamba, A Corpolongo, MF Salvatori, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 45 (2), 174-182, 2007
|Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients|
M Zaccarelli, V Tozzi, P Lorenzini, MP Trotta, F Forbici, ...
Aids 19 (10), 1081-1089, 2005
|Prevalence and risk factors for human immunodeficiency virus–associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort|
V Tozzi, P Balestra, P Lorenzini, R Bellagamba, S Galgani, A Corpolongo, ...
Journal of neurovirology 11 (3), 265-273, 2005
|Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy|
S Aleman, K Söderbärg, U Visco-Comandini, G Sitbon, A Sönnerborg
Aids 16 (7), 1039-1044, 2002
|Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART|
V Tozzi, P Balestra, D Serraino, R Bellagamba, A Corpolongo, P Piselli, ...
AIDS Research & Human Retroviruses 21 (8), 706-713, 2005
|Contamination by hepatitis B and C viruses in the dialysis setting|
N Froio, E Nicastri, UV Comandini, C Cherubini, R Felicioni, M Solmone, ...
American Journal of Kidney Diseases 42 (3), 546-550, 2003
|The Effect of age on response to therapy with peginterferon α plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr|
G Antonucci, MA Longo, C Angeletti, F Vairo, A Oliva, UV Comandini, ...
The American journal of gastroenterology 102 (7), 1383, 2007
|Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment|
S Aquaro, R D'Arrigo, V Svicher, GD Perri, SL Caputo, U Visco-Comandini, ...
Journal of antimicrobial chemotherapy 58 (4), 714-722, 2006
|Metformin in non-alcoholic steatohepatitis|
R Urso, U Visco-Comandini
The Lancet 359 (9303), 355-356, 2002
|Sporadic hepatitis C virus infection: a case-control study of transmission routes in a selected hospital sample of the general population in Italy|
UV Comandini, G Tossini, MA Longo, F Ferri, G Cuzzi, P Noto, ...
Scandinavian journal of infectious diseases 30 (1), 11-15, 1998
|Tuberculoid leprosy in a patient with AIDS: a manifestation of immune restoration syndrome|
U Visco-Comandini, B Longo, T Cuzzi, MG Paglia, G Antonucci
Scandinavian journal of infectious diseases 36 (11-12), 881-883, 2004
|Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02).|
A Amendola, L Bordi, C Angeletti, U Visco-Comandini, I Abbate, ...
Journal of acquired immune deficiency syndromes (1999) 31 (5), 488-494, 2002
|Specific Enfuvirtide-Associated Mutational Pathways in HIV-1 Gp41 Are Significantly Correlated With an Increase in CD4+ Cell Count, Despite Virological Failure|
S Valentina, S Aquaro, R D'Arrigo, A Artese, S Dimonte, S Alcaro, ...
The Journal of infectious diseases 197 (10), 1408-1418, 2008
|Monophyletic HIV type 1 CRF02-AG in a nosocomial outbreak in Benghazi, Libya|
U Visco-Comandini, G Cappiello, G Liuzzi, V Tozzi, G Anzidei, I Abbate, ...
AIDS research and human retroviruses 18 (10), 727-732, 2002
|Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus|
UV Comandini, P Maggi, P Santopadre, R Monno, G Angarano, V Vullo
European Journal of Clinical Microbiology and Infectious Diseases 16 (10 …, 1997
|Longitudinal quantification of human immunodeficiency virus type 1 DNA and RNA in long-term nonprogressors|
C Broström, U Visco-Comandini, Z Yun, A Sönnerborg
The Journal of infectious diseases 179 (6), 1542-1548, 1999
|Extent of HCV NS3 protease variability and resistance-associated mutations assessed by next generation sequencing in HCV monoinfected and HIV/HCV coinfected patients|
B Bartolini, E Giombini, P Zaccaro, M Selleri, G Rozera, I Abbate, ...
Virus research 177 (2), 205-208, 2013
|High urine IP-10 levels associate with chronic HCV infection|
L Petrone, T Chiacchio, V Vanini, E Petruccioli, G Cuzzi, C Di Giacomo, ...
Journal of Infection 68 (6), 591-600, 2014
|No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance|
U Visco-Comandini, D Lapa, C Taibi, C Angeletti, MR Capobianchi, ...
Digestive and Liver Disease 46 (4), 348-352, 2014